https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-462005-11-29 00:00:002019-02-15 09:19:48Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-62005-11-26 00:00:002019-02-15 09:19:50Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-952005-11-20 00:00:002019-02-15 08:38:52Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-82005-11-15 00:00:002005-11-15 00:00:00Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-62005-11-14 00:00:002019-02-15 09:11:49Immunological treatment of liver tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-10 / J. Clin. Oncol. 2005 Nov;23(32):8262-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-10 / J. Clin. Oncol. 2005 Nov;23(32):8262-92005-11-10 00:00:002019-02-15 09:24:19Prostate cancer immunology: biology, therapeutics, and challenges
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Int J Hyperthermia 2005 Nov;21(7):649-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Int J Hyperthermia 2005 Nov;21(7):649-562005-11-01 00:00:002019-02-15 10:00:37Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6B):4225-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6B):4225-302005-11-01 00:00:002019-02-15 08:53:28Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-142005-11-01 00:00:002019-02-15 09:23:49Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Clin. Cancer Res. 2005 Nov;11(21):7692-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Clin. Cancer Res. 2005 Nov;11(21):7692-92005-11-01 00:00:002019-02-15 09:19:56Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
